Swamy Venuturupalli, MD (@drswamyv) 's Twitter Profile
Swamy Venuturupalli, MD

@drswamyv

Member Board of Directors- ACR, Rheumatologist- Cedars Sinai, Researcher in digital health, Myositis, dietary interventions. Founder and CEO of @attunehealth

ID: 606694003

linkhttp://www.attunehealth.com calendar_today12-06-2012 22:28:09

1,1K Tweet

1,1K Takipçi

222 Takip Edilen

Swamy Venuturupalli, MD (@drswamyv) 's Twitter Profile Photo

I’m highly awaiting this talk. Leonard Calabrese is at the forefront of wellness research. Recommend this to all patients and family members of patients with #lupus #LupusAwarenessMonth

Donna Hoyne (@donna_hoyne) 's Twitter Profile Photo

2020 taught us that our collective actions matter more than ever. So we are excited to announce the inaugural Global Rheumatology Summit as one of several innovations we are pilot testing at #ACR21. We would be delighted to showcase your challenging case or innovation!

Daniel Kraft, MD (@daniel_kraft) 's Twitter Profile Photo

Israel’s Ministry of Health on Monday began offering a 3rd dose of the Pfizer vaccine to severely immunocompromised adults in what could be the first phase of an experiment to provide booster shots for older people and the most vulnerable. washingtonpost.com/world/israel-v…

American College of Rheumatology (@acrheum) 's Twitter Profile Photo

#ACR21 will build on the successes of last year’s virtual meeting while expanding engagement opportunities for participants. Learn more from @drswamyv → acr.tw/3pPEUYF

#ACR21 will build on the successes of last year’s virtual meeting while expanding engagement opportunities for participants. Learn more from @drswamyv → acr.tw/3pPEUYF
Leonard Calabrese (@lcalabresedo) 's Twitter Profile Photo

The inflammatory landscape of #COVID19 is complex in both children and adults- MIS-A is rare but devastating complication - Many lessons at #ACR21 today on disecting and treating this phase of COVID - #rheumatology peeps nned to be able to recognize MIS-A in adults Puja Mehta 🧩 🌻

The inflammatory landscape of #COVID19 is complex in both children and adults- MIS-A is rare but devastating complication - Many lessons at #ACR21 today on disecting and treating this phase of COVID - #rheumatology peeps nned to be able to recognize MIS-A in adults <a href="/DrPujaMehta1/">Puja Mehta 🧩 🌻</a>
American College of Rheumatology (@acrheum) 's Twitter Profile Photo

The ACR is aware of the emerging concerns surrounding access to needed treatments such as #MTX after the recent decision in Dobbs v. Jackson Women’s Health Organization.

The ACR is aware of the emerging concerns surrounding access to needed treatments such as #MTX after the recent decision in Dobbs v. Jackson Women’s Health Organization.
Leonard Calabrese (@lcalabresedo) 's Twitter Profile Photo

I have been following the vaccine dialogue and might be accused of going rogue-but if move toward different designs and platforms for a virus that will always be here we need a massive safety study to start -NO extrapolation Paul Sax Carlos del Rio Prof Peter Hotez MD PhD AJ Leonardi, MBBS, PhD

American College of Rheumatology (@acrheum) 's Twitter Profile Photo

Introducing a new ACR on Air series, In Practice, where we explore ways to aid busy clinicians in their practice. Listen in as guest Swamy Venuturupalli, MD talks tech solutions designed to improve efficiency, which have proven to work for his practice Attune Health → acronair.org

Introducing a new ACR on Air series, In Practice, where we explore ways to aid busy clinicians in their practice. Listen in as guest <a href="/DrSwamyV/">Swamy Venuturupalli, MD</a> talks tech solutions designed to improve efficiency, which have proven to work for his practice <a href="/AttuneHealth/">Attune Health</a> → acronair.org
Mark Pimentel MD (@markpimentelmd) 's Twitter Profile Photo

New paper today! We know anti-vinculin antibodies as an important biomarker of #IBS that I use in my clinic all the time. New collaboration confirms this test is also associated with objective GI effects of #scleroderma. A marker in this terrible disease. onlinelibrary.wiley.com/doi/10.1002/ac…

Rheumatology Research Foundation (@rheumresearch) 's Twitter Profile Photo

Community practitioners interested in conducting #rheumresearch in a clinical practice setting are invited to apply for our Community Practice Innovation Award. Letters of intent are due by Jan 15 & applications are due by Feb 1. Learn more & apply at RheumResearch.org/CPIA

Community practitioners interested in conducting #rheumresearch in a clinical practice setting are invited to apply for our Community Practice Innovation Award. Letters of intent are due by Jan 15 &amp; applications are due by Feb 1. Learn more &amp; apply at RheumResearch.org/CPIA
Rheumatology Research Foundation (@rheumresearch) 's Twitter Profile Photo

#Rheumatology practitioners interested in conducting research in a clinical setting: there are only a few days to submit your required, non-binding letter of requirement for the Community Practice Innovation Award! Learn more about how to apply at RheumResearch.org/CPIA

#Rheumatology practitioners interested in conducting research in a clinical setting: there are only a few days to submit your required, non-binding letter of requirement for the Community Practice Innovation Award! Learn more about how to apply at RheumResearch.org/CPIA